Diabetes Newswire

Live Results

1 - MannKind to Present at the Fourth Annual JMP Securities Healthcare Focus Conference

VALENCIA, Calif.-(Business Wire)-September 29, 2009 - MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Tuesday...

2 - Study Shows AFRESA® Provides Rapid Suppression of Endogenous Glucose Production in Diabetes Patients

VIENNA-(Business Wire)-September 29, 2009 - AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin able to more closely replicate normal glucose suppression than currently available insulins, according to data presented at the 45th Annual Meeting...

3 - Vitae Receives $8 Million Payment from Boehringer Ingelheim for Achievement of 11beta-HSD-1 Program Milestone

FORT WASHINGTON, Pa.-(Business Wire)-September 29, 2009 - Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their...

4 - Computable Genomix Announces Contest For Genomics Researchers

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...

5 - Research and Markets: "Improved Therapies and Innovative Drug Delivery Techniques Are Anticipated to Revolutionise the Global Diabetes Market by 2015," Notes the Analyst of This Research

DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets has detailed stringent policies for the approval of diabetic drugs. These policies compel lengthier clinical trials, often resulting in the delayed launch of new drugs and increased drug development costs. "The not-so conducive...

6 - Halozyme Begins Clinical Trial to Compare Three Insulin Analogs and Provides Update on Ultrafast Insulin Program

SAN DIEGO-(Business Wire)-September 28, 2009 - Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase...

7 - Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™ (sitagliptin/metformin)

WHITEHOUSE STATION, N.J.-(Business Wire)-September 25, 2009 - Merck & Co., Inc., issued the following statement today in response to the U.S. Food and Drug Administration's (FDA's) update on JANUVIA (sitagliptin) and JANUMET (sitagliptin/metformin). "Merck has thoroughly reviewed the safety data...

8 - Diabetes Foot Specialists Say Cost-Effective Wound Therapy Underused Due to Healthcare Reimbursement Incentives

-(Business Wire)-September 25, 2009 - WHAT: Every 30 seconds, across the globe an individual loses a limb due to poor diabetes management. In the U.S., diabetes affects nearly 24 million people. When poorly controlled, diabetes results in nerve damage and poor circulation to the legs and feet...

9 - NEVO™ Sirolimus-Eluting Coronary Stent Associated with Significantly Less Chest Pain at Six Months Than Taxus® Liberte® Stent

SAN FRANCISCO-(Business Wire)-September 24, 2009 - At six months, patients receiving the NEVO™ Sirolimus-eluting Coronary Stent reported significantly less chest pain (also known as angina) than those receiving the Taxus® Liberte® Stent. Patients also reported improvements in their overall...

10 - California Physician Organization Top Performers and Most Improved Honored by Integrated Healthcare Association

OAKLAND, Calif.-(Business Wire)-September 24, 2009 - In the midst of a national debate about the future of health care in America, the Integrated Healthcare Association (IHA) today announced the physician organizations that achieved overall performance in the top 20% in 2008 based on the statewide...

11 - Advanced BioHealing Showcases Dermagraft at Georgetown University’s Diabetic Limb Salvage Conference

WASHINGTON-(Business Wire)-September 24, 2009 - Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, today announced that Dermagraft®, its bio-engineered skin substitute that repairs tissue damaged by disease or injury and supports the body’s...

12 - Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009

SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) will unveil data from more than 20 studies at the 45th Annual Meeting of the European...

13 - Clinical Study Supports Accuracy of Store Brand TRUEresult Blood Glucose Monitoring System in Comparison to Name Brand Systems

FORT LAUDERDALE, Fla.-(Business Wire)-September 23, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced that a new study has shown that its TRUEresult® store brand blood glucose monitoring system is comparable to the...

14 - Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities

BOSTON-(Business Wire)-September 23, 2009 - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental...

15 - MSGI Announces First Nanobeak Product -- Handheld Bloodless Diabetes Test

NEW YORK-(Business Wire)-September 23, 2009 - MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood. Nanobeak Inc., an MSGI subsidiary, is a...

16 - 2.25 MM CYPHER® Sirolimus-eluting Coronary Stent Approved by FDA

BRIDGEWATER, N.J.-(Business Wire)-September 21, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the...

17 - Sloning Closes Growth Financing Round Led by LBBW Venture

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

18 - SUN CRYSTALS® Shines as New All-Natural Sweetener

FORT WASHINGTON, Pa.-(Business Wire)-September 21, 2009 - Love sugar but looking for a 100 percent natural, low-calorie way to stir up how you sweeten beverages, bake and cook? SUN CRYSTALS® All-Natural Sweetener from McNeil Nutritionals, LLC, is the first sweetener made from two simple ingredients...

19 - Covidien to Be Presenting Sponsor for American Diabetes Association EXPOs in New York and Minneapolis

NORTH HAVEN, Conn.-(Business Wire)-September 21, 2009 - Covidien (NYSE: COV), a leading global provider of health care products, today announced it will be the presenting sponsor of the American Diabetes Association’s Diabetes EXPOs in New York City and Minneapolis. In addition, Covidien is...

20 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...

21 - Incyte Announces Positive Top-Line Phase IIb Results for Topical INCB18424 in Psoriasis

WILMINGTON, Del.-(Business Wire)-September 21, 2009 - Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis. These results were obtained from a multi-center three-month Phase IIb trial...

22 - KCI Sponsors Georgetown Diabetic Limb Salvage Conference Symposium Featuring Top Limb Preservation Experts

SAN ANTONIO-(Business Wire)-September 18, 2009 - Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26. At the symposium...

23 - Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program

GREEN BAY, Wis.-(Business Wire)-September 18, 2009 - Integrative Therapeutics, Inc (ITI®), in collaboration with the American Association of Naturopathic Physicians (AANP), is seeking qualified residency sites for the fourth year of the ITI & AANP STAIRSM Residency Scholarship Program. This...

24 - New Program Offers Community Pharmacies an Expanded Role in Diabetes Self-Management Training, Increases Access and Treatment Options for Patients

ALEXANDRIA, Va.-(Business Wire)-September 17, 2009 - The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be...

25 - Hythiam Raises Approximately $7 Million in Registered Direct Offering

LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...

26 - NXT Nutritionals is Shipping SUSTA™ Natural Sweetener to Shaw’s, the Second-Largest Supermarket Chain in New England

HOLYOKE, Mass.-(Business Wire)-September 17, 2009 - NXT Nutritionals Holdings, Inc., (OTCBB: NXTH) announced it is shipping SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, in 50 Packet Boxes to New England’s second largest supermarket chain, Shaw’s...

27 - New Essentials Glycemic Health Brand Pasta Launched Using Hi-maize Natural Resistant Starch

BRIDGEWATER, N.J.-(Business Wire)-September 17, 2009 - National Starch Food Innovation today announced the launch of a new Hi-maize-enriched pasta by Racconto, a leading U.S. importer-producer of private label and branded Italian pasta. The all-natural Essentials Glycemic Health pasta line from...

28 - Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial

SUNRISE, Fla.-(Business Wire)-September 16, 2009 - Bioheart, Inc. (OTCBB:BHRT), presented positive efficacy data from part 1 of its Phase II/III clinical trial at the Heart Failure Society of America (HFSA) Meeting in Boston, Massachusetts. Thomas Povsic, MD, Ph.D., Assistant Professor of Medicine...

29 - CHI Launches Podcast Highlighting Disparities in Diabetes Care for Minorities

LA JOLLA, Calif.-(Business Wire)-September 16, 2009 - California Healthcare Institute: WHO:     Gary Puckrein, Ph.D., president and chief executive officer, National Minority Quality Forum   Kirk Geter, D.P.M., chief of podiatry, Howard University Hospital   David Gollaher, Ph.D., president...

30 - Alliance Health Networks Closes $3.3 Million Financing Led by Highway 12 Ventures

SALT LAKE CITY-(Business Wire)-September 16, 2009 - Alliance Health Networks, Inc. today announced that it has closed a $3.3 million Series C Preferred Stock financing led by Highway 12 Ventures. EPIC Ventures, Series B lead investor, also participated in the Series C round along with other...

31 - AVANIR to Present at the UBS Global Life Sciences Conference

ALISO VIEJO, Calif.-(Business Wire)-September 16, 2009 - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced that the Company will present at the UBS Global Life Sciences Conference on Wednesday, September 23rd at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) at the Grand Hyatt New York...

32 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets

WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...

33 - Home Diagnostics, Inc. Wins Governor’s Export Excellence Award

FORT LAUDERDALE, Fla.-(Business Wire)-September 15, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced that the company has received a 2009 Governor’s Export Excellence Award. The award, part of the 2009...

34 - PPD Opens Global Central Lab in Singapore

WILMINGTON, N.C.-(Business Wire)-September 15, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a...

35 - Medifacts Presents Free Symposium on “Meeting the Evolving Cardiac Safety Requirements from Diabetes to Oncology” at the North Carolina Biotech Center

-(Business Wire)-September 15, 2009 - Medifacts International: Who:   Medifacts International, Jeff Heilbraun and Boaz Mendzelevski, MD   Title: Recognizing the Cardiac Safety Continuum; Meeting the Evolving Cardiac Safety Requirements for New Medicinal Entities from Diabetes to Oncology...

36 - THE SAGE GROUP Supports the “Stop P.A.D.” Petition Drive to Expand Medicare Coverage to Test Patients for Peripheral Arterial Disease

ATLANTA-(Business Wire)-September 15, 2009 - In recognition of National P.A.D. Awareness Month, Mary L. Yost, President of THE SAGE GROUP recommends that patients, relatives, and the medical community join the campaign to increase access to a simple noninvasive test to diagnose peripheral arterial...

37 - AmMed Direct® Named Nashville’s Fastest-Growing Company

NASHVILLE, Tenn.-(Business Wire)-September 14, 2009 - AmMed Direct, a Nashville-based provider of diabetes testing supplies, prescription medications and support services for people with diabetes, has been named the fastest-growing private company in the Middle Tennessee area by the Nashville...

38 - Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009

DANBURY, Conn.-(Business Wire)-September 11, 2009 - Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the Morgan Stanley 2009 Global Healthcare Unplugged Conference in New York on Monday, September 14, 2009 at 4:30...

39 - VitalWear Launches Ad Campaign Based on Center for Disease Control Findings

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 11, 2009 - VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that it is launching a Direct Mail and Web campaign in an effort to educate customers on a recent report from the Center for Disease Control...

40 - Research and Markets: Australia Diabetes Care Devices Market Analysis and Forecasts Through to 2015

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the...

41 - Research and Markets: Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015 Reviews the Competitive Landscape In Terms Of Mergers and Acquisitions, Pipeline Products and Technology Offerings

DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy Understand what the new growth opportunities are within the...

42 - Research and Markets: Diabetic Neuropathy Therapy Area Pipeline Report - A Comprehensive Insight into the Pipeline Status of Diabetic Neuropathy Drugs

DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets has announced the addition of the "Diabetic Neuropathy Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Diabetic Neuropathy Therapy Area Pipeline Report contains detailed information on the diabetic...

43 - 1,500 Clinicians, 55 World-Renowned Clinical Experts, and 21 Medical Societies Convene in Boston for the 4th Annual Cardiometabolic Health Congress

BOSTON-(Business Wire)-September 10, 2009 - The 2009 Cardiometabolic Health Congress (CMHC) will hold its fourth annual meeting October 7–10, 2009, at the Sheraton Boston Hotel. “The current national debate on health care reform and health care cost has begun to focus attention on the issue...

44 - Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015

NEW YORK-(Business Wire)-September 10, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015...

45 - The Center for Wound Healing to Restate Certain 2008 and 2009 Financial Results

TARRYTOWN, N.Y.-(Business Wire)-September 10, 2009 - The Center for Wound Healing, Inc. (OTCBB:CFWH), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced that the...

46 - Research and Markets: Spain Diabetes Care Devices Market Analysis and Forecasts Through to 2015

DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the...

47 - NXT Nutritionals Launches SUSTA™ Natural Sweetener, Through White Rose Food, Which Distributes to 1,800 Stores from Maryland to Connecticut

HOLYOKE, Mass.-(Business Wire)-September 9, 2009 - As the first step in its campaign to bring SUSTA™ to major food retailers throughout the United States, NXT Nutritionals Holdings, Inc. (OTCBB:NXTH), developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier...

48 - Leading U.S. Epilepsy Organizations Unite on H1N1 Virus “Swine Flu” Public Health Recommendations for Children with Epilepsy

WEST HARTFORD, Conn. & CHICAGO & WASHINGTON & MIDDLEBURG, Va. & BOSTON & NEW YORK-(Business Wire)-September 9, 2009 - AES, CURE, Epilepsy Foundation, Epilepsy Therapy Project and FACES today announced their support for increased public awareness of H1N1 Virus (“Swine Flu...

49 - Research and Markets: The Top 20 Non-Invasive Blood Glucose Monitoring Device Companies Worldwide

DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets , a non-invasive blood glucose measurement device utilizing near-infrared spectroscopy. Report data field structure is as follows: Company Name Mailing Address Street Address Telephone Fax Email Website Parent Company Name Year...

50 - OSI Pharmaceuticals to Present at the Morgan Stanley Healthcare Conference on Tuesday, September 15, 2009

MELVILLE, N.Y.-(Business Wire)-September 8, 2009 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that OSI Management will present at the Morgan Stanley Healthcare Conference in New York, NY on Tuesday, September 15, 2009 at 3:20pm (Eastern Time) and will provide an overview on the...

51 - Emisphere Technologies Announces Publication in Clinical Pharmacology and Therapeutics of Encouraging Data from an Independent Clinical Study of an Oral Eligen-GLP-1 Formulation on Glucose Homeostasis

CEDAR KNOLLS, N.J.-(Business Wire)-September 8, 2009 - Emisphere Technologies, Inc. (OTC BB: EMIS) today announced the publication of an article in the September issue of Clinical Pharmacology and Therapeutics, that describes previously reported findings of an independent clinical study designed...

52 - ValenTx Completes $22 Million Series B Preferred Stock Financing

CARPINTERIA, Calif.-(Business Wire)-September 8, 2009 - ValenTx, Inc., announced today the closing of a $22 million Series B Preferred Stock financing. The round was led by SV Life Sciences and joined by Covidien Ventures, as well as all the Company’s existing venture capital investors: Sapient...

53 - Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009

AMITYVILLE, N.Y.-(Business Wire)-September 4, 2009 - Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its first quarter of Fiscal Year 2010 ended July 31, 2009, prior to the market opening on Wednesday September 9, 2009 and will hold a conference call to...

54 - New Mintel Survey Shows Americans in Denial about Health

CHICAGO-(Business Wire)-September 3, 2009 - We think we’re healthier than we actually are, suggests a new survey from market research leader Mintel. Surveying Americans about their health, Mintel found people’s perceptions strongly contradict national statistics about obesity, illness and...

55 - Reportlinker Adds Global Diabetes Care Devices Market Analysis and Forecasts to 2015

NEW YORK-(Business Wire)-September 3, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Global Diabetes Care Devices Market Analysis and Forecasts to 2015...

56 - New Diabetes Device May Be Next Step in Quest for Artificial Pancreas

MINNEAPOLIS-(Business Wire)-September 2, 2009 - At this year’s annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. (NYSE: MDT) announced the global launch of a novel technology designed to provide additional protection...

57 - Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

IRVINE, Calif.-(Business Wire)-September 2, 2009 - Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Dr. Varney will...

58 - Health Care Crisis News with Rosalie Michaels Goes Live Sept. 1, 2009

PHOENIX-(Business Wire)-September 1, 2009 - As Washington prepares to battle for America's health, a former Mrs. Arizona takes a humorous approach to America's greatest problem. "I am watching the news and I see Americans wanting to kill each other at town halls just so they can figure out a way...

59 - Toledo-Based ProMedica Health System Introduces Program Series to Target Obesity

TOLEDO, Ohio-(Business Wire)-September 1, 2009 - Toledo, Ohio-based ProMedica Health System (PHS) will launch the second year of a health and wellness initiative called Fields of Green to address northwest Ohio’s and southeast Michigan’s obesity problem. According to the 2009 Ohio Family...

60 - NCPA Urges Congressional Action This Month to Block Severe Medicaid Cuts to Pharmacies

ALEXANDRIA, Va.-(Business Wire)-September 1, 2009 - The National Community Pharmacists Association (NCPA) is urging Congressional action in the next 30 days to preserve the access Medicaid patients have to approximately 23,000 community pharmacies. When the Medicare Improvements for Patients and...

61 - Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis’ President, CEO & CSO

SAN DIEGO-(Business Wire)-September 1, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Mark Erion, PhD, the Company’s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director of the...

62 - Redpoint Bio to Present at Rodman & Renshaw Annual Global Investment Conference

EWING, N.J.-(Business Wire)-September 1, 2009 - Redpoint Bio Corporation (OTCBB: RPBC), a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced that Dr. Ray Salemme, Chief Executive Officer of Redpoint Bio...

63 - Reportlinker Adds World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024

NEW YORK-(Business Wire)-September 1, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024...

64 - Reportlinker Adds Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015

NEW YORK-(Business Wire)-September 1, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015...

65 - Bio-Matrix Scientific Group Inc. Chairman Comments on New Opportunities for both the Company and Its Majority Owned Subsidiary Entest BioMedical Inc.

SAN DIEGO-(Business Wire)-September 1, 2009 - Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property. Mr. Koos noted, “In the last 3 months we have made...

66 - Study in Annals of Internal Medicine Finds Mediterranean-Style Diet More Effective than Low-Fat Diet In Reducing Need for Drug Therapy in Patients with Newly Diagnosed Type 2 Diabetes

PHILADELPHIA-(Business Wire)-August 31, 2009 - A study published in Annals of Internal Medicine found that compared with a low-fat diet, a low-carbohydrate Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for...

67 - First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER® Sirolimus-Eluting Coronary Stent

BRIDGEWATER, N.J.-(Business Wire)-August 31, 2009 - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range...

68 - Geron to Present at Four Investor Conferences

MENLO PARK, Calif.-(Business Wire)-August 31, 2009 - Geron Corporation (Nasdaq:GERN) today announced that the company will present updates of its product development programs at four investor conferences in the month of September. Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice...

69 - Tethys Bioscience Announces Personnel Additions and Promotions

EMERYVILLE, Calif.-(Business Wire)-August 31, 2009 - Tethys Bioscience, Inc. announced today that former Chief Business Officer Michael Richey has been promoted to President, and that several key executives have joined the company’s management team. In the last twelve months the company has...

70 - Research and Markets: Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-August 27, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information...

71 - Research and Markets: Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-August 27, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and...

72 - GfK Healthcare’s Roper Diabetes Patient Programme Launches Enhanced Annual Study for Western Europe: Six Focused Research Waves Across Five Countries

LONDON-(Business Wire)-August 26, 2009 - GfK Healthcare’s Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five...

73 - Data from a Clinical Study Evaluating GI Dynamics’ EndoBarrier to be Presented at IFSO

PARIS-(Business Wire)-August 26, 2009 - GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao...

74 - USANA-Supported Clinical Study Results Published in the Journal Obesity and Weight Management

SALT LAKE CITY-(Business Wire)-August 25, 2009 - USANA Health Sciences, Inc. (NASDAQ: USNA) announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the...

75 - Advance Auto Parts Launches 2009 National “Sneaker” Sales Campaign to Support Juvenile Diabetes Research Foundation (JDRF)

ROANOKE, Va.-(Business Wire)-August 25, 2009 - Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket retailer of parts, batteries, accessories, and maintenance items, and a national partner of the Juvenile Diabetes Research Foundation (JDRF), is proud to announce the launch of its...

76 - Finalists From Germany, France and Switzerland Nominated for The EUROPEAN BIOTECHNICA AWARD 2009

HANNOVER, Germany-(Business Wire)-August 25, 2009 - The EUROPEAN BIOTECHNICA AWARD jury has selected the three finalists for 2009: The nominees are the biopharmaceutical companies NovImmune, Switzerland, TRION Pharma GmbH, Germany, and VIVALIS, France. The award, with prize money totalling 100,000...

77 - Center for Health Value Innovation Endorses National Diabetes Goal to Ensure Awareness, Improve Management of Type 2 Diabetes

ST. LOUIS-(Business Wire)-August 24, 2009 - The Center for Health Value Innovation (www.vbhealth.org), the nation’s premier information exchange for value-based design, today joined with other non-profits, healthcare provider groups, universities, government officials, and corporations to fully...

78 - Fresenius Medical Care Gives Dialysis Patients Freedom To Travel This Fall and Winter

WALTHAM, Mass.-(Business Wire)-August 24, 2009 - As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from...

79 - Research and Markets: Minimally Invasive Blood Glucose Monitoring device Clinical Trial Analysis

DUBLIN-(Business Wire)-August 21, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Minimally Invasive Blood Glucose Monitoring device Clinical Trial Analysis" to their offering. Minimally Invasive Blood Glucose Monitoring device Clinical Trial Analysis...

80 - Research and Markets: The Impact of Novo Nordisk Discontinuing Its Involvement in the Inhaled Insulin iDMS Programme Will Be Mixed Latest 2009 Company Profile Considers This and More

DUBLIN-(Business Wire)-August 21, 2009 - Research and Markets. Sales, Costs and Operating Income Profitability and Research Ratios. R&D Expenditure and Capital Expenditure Current Assets, Liabilities and Ratio Assets, Cash and Liquidity. Employees and Productivity Companies Mentioned: Argos...

81 - Tips for Taking the Sting out of the Rest of Summer from myOptumHealth.com

GOLDEN VALLEY, Minn.-(Business Wire)-August 20, 2009 - With all the good times summer has to offer, why let Mother Nature spoil the fun with those pesky insect bites? Here’s how to avoid the itching and stinging from insect bites and poisonous plants, even later in the season. Preventing insect...

82 - Oak Park Unified School District Cafeteria Staff Learn to Cook Healthy Menus from California Health & Longevity Institute Nutrition Experts

WESTLAKE VILLAGE, Calif.-(Business Wire)-August 20, 2009 - Children and teens returning to school in the Oak Park Unified School District this September have healthier options for school lunches, thanks to nutrition experts at California Health & Longevity Institute. Cafeteria staff from the...

83 - Research and Markets: European Insulin Delivery Devices Market Outlook - High Prevalence of Diabetes in Europe Drives the Insulin Delivery Devices Market

DUBLIN-(Business Wire)-August 20, 2009 - Research and Markets producers and insulin delivery device suppliers. "Cooperative agreements and projects will help both medical device and pharmaceutical companies benefit from mutual synergies," concludes the analyst. "Such an approach would enable both...

84 - BMI of Texas Bariatric Surgeons Selected as National Training Center for REALIZE Gastric Band

SAN ANTONIO-(Business Wire)-August 19, 2009 - The Bariatric Medical Institute of Texas (“BMI of Texas”) today announced surgeons Mickey Seger and Terive Duperier have been selected by Ethicon Endo-Surgery, Inc. as one of the five training sites in the U.S. to host a preceptorship for the Ethicon...

85 - SANUWAVE, Inc. Adds Southern Arizona VA Medical Center to its dermaPACE™ Investigational Device Exemption Clinical Trial for Diabetic Foot Ulcers

ALPHARETTA, Ga.-(Business Wire)-August 19, 2009 - SANUWAVE, Inc., (www.sanuwave.com) an emerging leader in the development and commercialization of noninvasive, biologic response activating devices in the regenerative medicine segment, has added Southern Arizona VA in Tucson, Arizona as the newest...

86 - Research and Markets: Insulin Delivery Systems Market Analysis Report: 2008-2012 - Increase of Diabetes Patients Globally is Proving a Boom for Diabetes Drugs Market

DUBLIN-(Business Wire)-August 18, 2009 - Research and Markets ", states that currently the insulin market is characterized by emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also. As a result, global insulin market is...

87 - Metabolon Experts to Lead Discussions at International Metabolomics Society Meeting

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-August 18, 2009 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, will participate as invited speakers and discussion facilitators at the fifth annual International Conference of the Metabolomics Society. The...

88 - Oculus Innovative Sciences Announces Microcyn® Skin and Wound Cleanser with Preservatives Now Commercially Available in the United States

PETALUMA, Calif.-(Business Wire)-August 18, 2009 - Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today commercialized its Microcyn® Skin and Wound Cleanser with...

89 - L.A. Could Lead Nation as Supes Vote on Landmark Motion Calling for 100% Nutritious Vending Options

-(Business Wire)-August 18, 2009 - California Center for Public Health Advocacy: WHAT:   Responding to county public health statistics which show that more than half the county’s adults are overweight with rising levels of diabetes, hypertension and heart disease related to obesity, the Los...

90 - GlycoMimetics, Inc. Awarded NIH Grant to Study Drug Candidate in Diabetes

GAITHERSBURG, Md.-(Business Wire)-August 17, 2009 - GlycoMimetics, Inc., a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced it has been awarded a grant from The National Heart, Lung, and Blood...

91 - TIGroup Announces Third Quarter Results, New Growth Initiatives And Medical Advisory Board

BEVERLY HILLS, Calif.-(Business Wire)-August 17, 2009 - Tri-Isthmus Group, Inc. (TIGroup) (OTC BB: TISG), a provider of financial solutions to the healthcare services industry, announced today results for the company’s third fiscal quarter ended June 30, 2009. The company also announced the...

92 - PTS, Inc. Hails New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer’s Disease or Vascular Dementia

INDIANAPOLIS-(Business Wire)-August 17, 2009 - Polymer Technology Systems, Inc. (PTS, Inc.), manufacturer of the CardioChek® PA point-of-care instrument and the CardioChek® home cholesterol analyzer, released a statement today hailing the new study by Kaiser Permanente that suggests high...

93 - CRC Health Corporation Reports Operating Results for the Second Quarter and Six Months Ended June 30, 2009

CUPERTINO, Calif.-(Business Wire)-August 14, 2009 - CRC Health Corporation ("CRC" or the "Company"), a leading provider of substance abuse treatment and youth services through its wholly owned consolidated subsidiaries, announced its results for the three months and six months ended June 30, 2009...

94 - Research and Markets: Glucose Monitoring Clinical Trial Analysis Report: Essential Data from the World's Glucose Monitoring Manufacturers

DUBLIN-(Business Wire)-August 14, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Glucose Monitoring Clinical Trial Analysis" to their offering. Glucose Monitoring Clinical Trial Analysis "Glucose Monitoring Clinical Trials Analysis" is an essential...

95 - Research and Markets: Mexico Dental Devices - A Comprehensive Report Including Investment Opportunities, Analysis and Forecasts Through to 2015

DUBLIN-(Business Wire)-August 14, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Mexico Dental Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and data...

96 - Tranzyme Pharma to Present at American Chemical Society (ACS) 2009 National Meeting

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-August 14, 2009 - Tranzyme Pharma, a late stage biopharmaceutical company engaged in the discovery and development of first-in-class small molecule therapeutics, announced today that Mark L. Peterson, PhD., Tranzyme’s Vice President of Intellectual...

97 - Aetna Grant to Fund Anti-Obesity Education Project

ATLANTA-(Business Wire)-August 13, 2009 - Atlanta’s Center for Puppetry Arts today unveiled “Little Noodle,” a brand-new puppet created to teach children and their families the importance of health eating and exercise. “Little Noodle,” funded by a $50,000 grant from Aetna (NYSE: AET) and...

98 - Maryland Governor Martin O’Malley and JDRF Lead Distinguished Group of 2009 “Stem Cell Action” Honorees

WASHINGTON-(Business Wire)-August 13, 2009 - The Genetics Policy Institute (GPI) will honor Maryland Governor Martin O’Malley, the Juvenile Diabetes Research Foundation (JDRF), two leading Michigan stem cell organizations and two patient-advocates who serve on the Maryland Stem Cell Commission...

99 - Redpoint Bio Reports Three Months and Six Months 2009 Results

EWING, N.J.-(Business Wire)-August 13, 2009 - Redpoint Bio Corporation (OTCBB:RPBC), a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced financial and operational results for the three months and six...

100 - Barry Ross Appointed as VP of Business Development for Santal Solutions, LLC

NEENAH, Wis.-(Business Wire)-August 12, 2009 - Santal Solutions, LLC (www.santalsolutions.com) is pleased to announce the appointment of Barry Ross as VP of Business Development. Barry will oversee all global business development for the sales and distribution of Santal Solutions’ all-natural...

101 - As Aging Populations Rise, World-Renowned Aging Experts Will Convene to Share Insights into How to Achieve a Healthy Lifespan

CAMBRIDGE, Mass.-(Business Wire)-August 11, 2009 - The world’s foremost thought leaders in the science of aging will convene at Harvard in September to discuss the question that has perplexed people since Ponce de Leon first sought out the Fountain of Youth, “can we live longer and healthier...

102 - Jordin Sparks Designs Office Depot Backpack for Charity at Teen Choice 2009: Photo Available on Business Wire's Web Site and AP PhotoExpress

BOCA RATON, Fla.-(Business Wire)-August 11, 2009 - “American Idol” winner, Jordin Sparks, in the Backstage Creations Celebrity Gift Retreat at Teen Choice 2009. Celebrities autographed and designed backpacks provided by Office Depot and Sharpie’s “My Project Backpack” program to be...

103 - New Roche Mycoplasma PCR Test Replaces Time-Consuming Culture Testing During Pharmaceutical Production

PENZBERG, Germany-(Business Wire)-August 11, 2009 - In July 2009 the new MycoTOOL PCR test from Roche Applied Science was approved by the European Medicines Agency (EMEA) for release testing of a Roche pharmaceutical product. It is the first commercially available Mycoplasma PCR test that can...

104 - Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients

BOULDER, Colo.-(Business Wire)-August 10, 2009 - Array BioPharma Inc. (Nasdaq: ARRY) today announced positive top-line data from a Phase 1 clinical trial in patients with Type 2 diabetes with its novel small molecule glucokinase activator (GKA), ARRY-403. The drug met its primary and secondary...

105 - Clemmy’s Ice Cream Steps up Efforts to Encourage Healthier Eating

RANCHO MIRAGE, Calif.-(Business Wire)-August 10, 2009 - When Jon Gordon, the founder of Clemmy’s Ice Cream, the world’s first and only commercially-produced sugar free, all natural ice cream recently read about Whole Foods Market’s CEO John Mackey’s concept to reposition the chain as a...

106 - NXT Nutritionals Announces Formation of Medical Advisory Board

HOLYOKE, Mass.-(Business Wire)-August 7, 2009 - NXT Nutritionals Holdings, Inc. (“NXT Nutritionals”) (OTCBB: NXTH) a developer and marketer of proprietary, patent-pending healthy natural sweeteners, food and beverage products, announces today that the Company will be forming a Medical Advisory...

107 - Life Extension Still the Only Supplier of Certified Authentic Irvingia gabonensis

FORT LAUDERDALE, Fla.-(Business Wire)-August 7, 2009 - In October 2008, Life Extension® launched a weight loss product which contains the patented Integra-Lean™ Irvingia, a proprietary extract of the seed of the West African mango fruit Irvingia gabonensis. Since then, Irvingia products without...

108 - Halozyme Therapeutics Reports Second Quarter 2009 Financial Results

SAN DIEGO-(Business Wire)-August 7, 2009 - Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for...

109 - Research and Markets: Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-August 6, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the...

110 - Humana Military Healthcare Services Receives Accreditation in Diabetes Disease Management Program

LOUISVILLE, Ky.-(Business Wire)-August 6, 2009 - Humana Military Healthcare Services, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), recently received accreditation for its Disease Management Program – Diabetes and its first re-accreditation for Disease Management programs in Asthma and...

111 - The Home Diagnostics TRUE Family of Products Make Diabetes Testing More Affordable

FORT LAUDERDALE, Fla. & ATLANTA-(Business Wire)-August 6, 2009 - American Association of Diabetes Educators (AADE) 36th Annual Meeting, Booth #126 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, is making diabetes testing more...

112 - MannKind to Present at the 29th Annual Canaccord Adams Global Growth Conference

VALENCIA, Calif.-(Business Wire)-August 6, 2009 - MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 29th Annual Canaccord Adams Global Growth Conference on Wednesday, August 12...

113 - Fresenius Medical Care to Host 100 Free Public Education Classes During ANNA’s Kidney Disease Awareness and Education Week

WALTHAM, Mass.-(Business Wire)-August 6, 2009 - Fresenius Medical Care North America, operator of the nation’s leading network of dialysis facilities, is hosting over 100 free Treatment Options Program (TOPs) education classes about chronic kidney disease (CKD) next week. TOPs sessions will be...

114 - Research and Markets: Italy Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-August 6, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Italy Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and data...

115 - Home Diagnostics Reports Second Quarter 2009 Financial Results

FORT LAUDERDALE, Fla.-(Business Wire)-August 6, 2009 - Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced financial results for the second quarter ended June 30, 2009. Total revenue for the second quarter was $32.7 million, a...

116 - DexCom to Present at the 29th Annual Canaccord Adams Global Growth Conference

SAN DIEGO-(Business Wire)-August 5, 2009 - DexCom, Inc. (NASDAQ:DXCM) today announced that Steven Pacelli, Chief Administrative Officer, will present an update on DexCom at the Canaccord Adams Global Growth Conference in Boston on Tuesday, August 11, 2009 at 11:30 a.m. (EDT). The presentation, which...

117 - Forward Reports Fiscal 2009 Third Quarter Results

POMPANO BEACH, Fla.-(Business Wire)-August 5, 2009 - Forward Industries, Inc. (NASDAQ:FORD), a designer and distributor of custom carrying case solutions, today announced financial results for its third fiscal quarter ended June 30, 2009. Fiscal 2009 Third Quarter Financial Results – Compared to...

118 - Welch Allyn Connectivity Website Assists Physicians with Transition to the Digital Age

SKANEATELES FALLS, N.Y.-(Business Wire)-August 5, 2009 - Welch Allyn, a leading global manufacturer of frontline products and solutions, today introduced an online tool designed to educate doctors on the benefits of connectivity. The new website (www.welchallyn.com/wafor/connectivity/cp-default.htm...

119 - Reportlinker Adds United States Diabetes Care Devices Market Analysis & Forecasts to 2015

NEW YORK-(Business Wire)-August 5, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds United States Diabetes Care Devices Market Analysis & Forecasts to 2015...

120 - CyGene Introduces First Predictive Genetic Products in Russia

CORAL SPRINGS, Fla.-(Business Wire)-August 4, 2009 - CyGene Laboratories Inc. (OTC: CYGE) announced today that its direct-to-consumer predictive genetic products have been introduced in the Russian Federation by its exclusive licensee CyGene Russia, LLC. The CyGene products are the first...

121 - U.S. Patent to be Granted for Aushon Microarray Printing Technology

BILLERICA, Mass.-(Business Wire)-August 4, 2009 - Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis has announced that its request for a U.S. patent covering its advanced microarray printing...

122 - Mesynthes Seeks U.S. FDA Clearance for First Product Employing Proprietary Endoform™ Extracellular Matrix Technology

WELLINGTON, New Zealand-(Business Wire)-August 4, 2009 - Mesynthes, a privately held tissue regeneration company, today announced it has filed a Premarket Notification [510(k)] with the U.S. Food and Drug Administrative for the company’s Endoform Dermal Template™ for use in the treatment of...

123 - Freedom Meditech, Inc. Secures Second Tranche of Series A Financing

CLEVELAND & SAN DIEGO-(Business Wire)-August 4, 2009 - Freedom Meditech, Inc., the developer of proprietary non-invasive ophthalmic medical device technologies for people with diabetes, today announced that the company closed on the second round of its Series A financing. The amount of financing...

124 - Research and Markets: UK Diabetes Care Devices Market Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-August 4, 2009 - Research and Markets , partnerships, venture capital and private equity investments. Qualitative analysis of market drivers, market limiters regulatory issues and future outlook. Reasons to buy: Understand what the new growth opportunities are within the UK...

125 - DexCom Inc. Reports Second Quarter 2009 Financial Results

SAN DIEGO-(Business Wire)-August 3, 2009 - DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results for the quarter ended June 30, 2009. Product revenue grew to approximately $4.1 million for the second quarter of 2009, an increase of 112% from the $1.9 million in product revenue...

126 - Highwoods Properties Signs 91,000 Square Foot First Generation Lease at Cool Springs IV

RALEIGH, N.C.-(Business Wire)-August 3, 2009 - Highwoods Properties, Inc. (NYSE: HIW), the largest owner and operator of suburban office properties in the Southeast, today announced that it has signed a long-term lease at Cool Springs IV, totaling 91,253 square feet of first generation space, with...

127 - Neurotez, Inc. Awarded Multi-Million Dollar NIH Grant to Advance a Leptin Product into Clinical Trials for Treating Alzheimer’s Disease.

BRIDGEWATER, N.J.-(Business Wire)-August 3, 2009 - The National Institutes of Health (NIH), through the Small Business Innovation and Research (SBIR) Program, has awarded Neurotez, Inc. a $2.73-million dollar, three-year grant to initiate the clinical development of a Leptin product as a novel...

128 - U.S. Food and Drug Administration Approves ONGLYZA™ (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults

PRINCETON, N.J. & LONDON-(Business Wire)-July 31, 2009 - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as...

129 - Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2010

CAMBRIDGE, Mass.-(Business Wire)-July 30, 2009 - Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. ET on Thursday, August 6, 2009, to discuss the company’s financial results for the first quarter of fiscal 2010. Management will review the quarter and provide an update on the...

130 - Phase Forward Named to FORTUNE Small Business 100 List of Fastest-Growing Public Companies

WALTHAM, Mass.-(Business Wire)-July 30, 2009 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, is included in the FORTUNE Small Business 100 list for the second consecutive year, ranking 20th among America’s fastest-growing small...

131 - Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2009 Financial Results

SAN DIEGO-(Business Wire)-July 29, 2009 - Metabasis Therapeutics, Inc. (Nasdaq: MBRX), a biopharmaceutical company that has established an existing pipeline of product candidates and advanced discovery programs targeting large markets with significant unmet needs including hyperlipidemia, diabetes...

132 - Nutrisystem, Inc. Reports Second Quarter 2009 Results; Announces Quarterly Dividend of $0.175 Per Share

HORSHAM, Pa.-(Business Wire)-July 29, 2009 - Nutrisystem, Inc. (NASDAQ:NTRI), a leading provider of weight management products and services, today reported financial results for the second quarter of 2009, including expected diluted EPS of $0.28 after the impact of the previously announced Zero...

133 - Alkermes’ Corporate Presentation to be Webcast at the BMO Capital Markets 9th Annual Focus on Healthcare Conference

CAMBRIDGE, Mass.-(Business Wire)-July 29, 2009 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by BMO Capital Markets on Wednesday, August 5, 2009, at 1:15 p.m. ET from the Millennium Broadway Hotel in New York City. The presentation may be...

134 - Diagnostic Devices, Inc.’s Low-Cost Prodigy™ Blood Glucose Meters Now Medicaid-Covered in Illinois and Missouri

CHARLOTTE, N.C.-(Business Wire)-July 29, 2009 - Diagnostic Devices, Inc. (DDI) has signed contracts with the states of Illinois and Missouri that will result in its Prodigy™ line of blood glucose monitoring systems and test strips being covered under Medicaid in those states. With the agreements...

135 - Elron Group Company Medingo Receives Formal FDA Clearance to  Market Its Insulin Micropump in the United States

TEL AVIV, Israel-(Business Wire)-July 28, 2009 - Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) announced today, that further to it previous announcement on July 28, 2009, Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC – Rafael Development Corporation Ltd., has...

136 - Research and Markets: US Insulin Delivery Devices: Patient Acceptance Drives Demand

DUBLIN-(Business Wire)-July 28, 2009 - Research and Markets has announced the addition of GlobalData 's new report "US Insulin Delivery Devices: Patient Acceptance Drives Demand" to their offering. Our "US Insulin Delivery Devices Market: Patient Acceptance Drives Demand" report is an essential...

137 - Elron Group Company Medingo Receives Informal Clearance Notice from FDA to Market Its Insulin MicroPump in the United States

TEL AVIV, Israel-(Business Wire)-July 28, 2009 - Elron Electronic Industries Ltd. (NASDAQ:ELRN) (TASE:ELRN) today announced that Medingo Ltd., a group company held 92% by Elron and its subsidiary RDC – Rafael Development Corporation Ltd., has received an informal notice, by electronic mail, that...

138 - Mach One Corporation Signs Letter of Intent to Acquire White Hat Brands, LLC

BELGIUM, Wis.-(Business Wire)-July 28, 2009 - Mach One Corporation (OTC Bulletin Board: MNCN), a rapidly growing innovative global wellness solutions company, announced today that it has signed a Letter of Intent to acquire Atlanta-based White Hat Brands, LLC, producers of a variety of...

139 - Osiris Achieves Milestone Payment for Progress Developing Stem Cell Therapy for Type 1 Diabetes

COLUMBIA, Md.-(Business Wire)-July 28, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem...

140 - MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 3, 2009

VALENCIA, Calif.-(Business Wire)-July 27, 2009 - MannKind Corporation (Nasdaq: MNKD) will release its 2009 second quarter financial results on Monday, August 3, 2009. Management of the Company will host a conference call to discuss the second quarter financial results and other Company...

141 - Iron-Binding Drug Could Help Diabetics Heal Stubborn Wounds, Says Stanford/Einstein Study

STANFORD, Calif.-(Business Wire)-July 27, 2009 - A drug used to remove iron from the body could help doctors fight one of diabetes’ cruelest complications: poor wound healing, which can lead to amputation of patients’ toes, feet and even legs. The drug, deferoxamine, helped diabetic mice heal...

142 - DexCom Schedules Second Quarter 2009 Earnings Release and Conference Call for August 3, 2009

SAN DIEGO-(Business Wire)-July 27, 2009 - DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2009 financial results after market close on Monday, August 3, 2009. Management will hold a conference call to review the company's second quarter financial performance...

143 - Medica and Fairview Sign Unique Contract That Addresses Health Care Cost

MINNEAPOLIS-(Business Wire)-July 27, 2009 - Medica and Fairview today announced the two Minnesota health care organizations have signed a contract that demonstrates health care reform can be addressed from within the health care system. Reached through a collaborative process, the agreement is...

144 - Heartland Sweeteners Unveils the “Ideal® vs. Sugar Taste Challenge”

INDIANAPOLIS-(Business Wire)-July 27, 2009 - At the American Association of Diabetes Educators (AADE) Annual Conference in Atlanta this month, Heartland Sweeteners will introduce the taste challenge between its Ideal® sweetener and sugar, before expanding to other markets in the Midwest and East...

145 - Ross Valley Pharmacy Offers Consumers Personalized Medication & Nutrition Counseling to Identify Potential Side-Effects, Educate Consumers & Improve Health Outcomes

LARKSPUR, Calif.-(Business Wire)-July 27, 2009 - Ross Valley Pharmacy, an independent, locally owned pharmacy in Marin County, Calif., announced today the availability of personalized medication management (MM) and diabetes counseling programs. The MM program is designed to help local residents...

146 - Olympia Dukakis & Louis Zorich Share Type 2 Diabetes Stories on EmpowHer

SCOTTSDALE, Ariz.-(Business Wire)-July 23, 2009 - Academy Award-winning actress Olympia Dukakis and her husband, actor Louis Zorich, have shared their diabetes stories to help increase awareness, announced EmpowHer (www.empowher.com), the home of women’s health online. After Mr. Zorich was...

147 - Chinese Scientist Fanyi Zeng to Present at World Stem Cell Summit on iPS Cells Producing Viable Mice

WASHINGTON-(Business Wire)-July 23, 2009 - Fanyi Zeng, PhD., MD., of the Institute of Medical Genetics, Shanghai Jiao Tong University, a principal investigator in a new paper published in the scientific journal Nature this week, will present her work at the upcoming 2009 World Stem Cell Summit...

148 - Diabetes Educators Get First Taste of Nevella® with Probiotics, the Only Sweetener Designed to Boost the Immune System

INDIANAPOLIS-(Business Wire)-July 23, 2009 - Designed to boost the immune system and promote health, probiotics are gaining popularity at the grocery, and Nevella® with Probiotics (www.nevella.com), made by Heartland Sweeteners, is the first and only such sweetener currently on the market. Diabetes...

149 - Home Diagnostics to Report Second Quarter 2009 Financial Results on August 6, 2009

FORT LAUDERDALE, Fla.-(Business Wire)-July 23, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced details relating to its second quarter 2009 earnings announcement, which will take place before the market opens on...

150 - OSI Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results

MELVILLE, N.Y.-(Business Wire)-July 22, 2009 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today its financial results for the Company’s second quarter ended June 30, 2009. The Company reported total revenues from continuing operations of $99 million for the second quarter of 2009...

151 - A Proprietary Next-Generation Extract of an Ancient Indian Plant Leads to a Scientific Breakthrough for Helping Maintain Blood Sugar and Cholesterol Levels*†

NEENAH, Wis.-(Business Wire)-July 22, 2009 - A scientific breakthrough by Ayurvedic-Life International (www.ayurvedic-life.com), a leading biotech firm in Neenah, Wisconsin, has led to a proprietary next-generation extract of an ancient Indian plant called Gymnema sylvestre that helps human beings...

152 - Depomed Provides License for Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.

MENLO PARK, Calif.-(Business Wire)-July 22, 2009 - Depomed, Inc. (NASDAQ:DEPO) today announced that it has provided a license to certain patents directed to metformin extended release technology to Merck & Co., Inc. to be used in developing fixed dose combinations of sitagliptin and extended...

153 - Reportlinker Adds Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

NEW YORK-(Business Wire)-July 22, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015...

154 - Krames Patient Education Launches Multimedia Chronic Disease Self-Management Workbooks for the Web

YARDLEY, Pa.-(Business Wire)-July 21, 2009 - Krames, the leaders in patient education, has announced the release of Krames Go-to-GuidesTM, a series of multimedia online workbooks. Go-to-GuideTM programs have been created for Type 2 Diabetes, Coronary Artery Disease, Heart Failure, Asthma, and COPD...

155 - MDVIP Named as a Top 10 Executive Health Program by Worth Magazine

BOCA RATON, Fla.-(Business Wire)-July 21, 2009 - MDVIP, a leading national group of affiliated primary care physicians who emphasize preventive care, has been named as a top ten provider of annual comprehensive executive physicals according to Worth magazine. The financial and lifestyle...

156 - Exenatide Once Weekly Provided Superior Glucose Control Compared To Lantus® in Head-to-Head DURATION-3 Study

SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass.-(Business Wire)-July 20, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced positive results from a study comparing subjects randomized to either exenatide once...

157 - Atlanta City Council Honors Aetna

ATLANTA-(Business Wire)-July 20, 2009 - Atlanta’s City Council today issued a proclamation commending Aetna (NYSE: AET) for supporting programs and raising awareness of the growing health problems of childhood obesity and diabetes in the Metro Atlanta community. Atlanta City Councilman Kwanza Hall...

158 - MedVentive Secures $7.25M Funding Led by Excel Venture Management and HLM Venture Partners

WALTHAM, Mass.-(Business Wire)-July 16, 2009 - MedVentive, the leading provider of integrated performance management solutions for health plans and providers, is pleased to announce the next phase of its growth will be fueled by a new Series C $7.25M investment. New investor, Excel Venture...

159 - AMS 700® with INHIBIZONE® Approved by FDA as the Only Inflatable Penile Prosthesis Proven to Reduce Infection

MINNEAPOLIS-(Business Wire)-July 16, 2009 - American Medical Systems, Inc. (AMS) (NASDAQ: AMMD) a trusted provider of medical solutions for restoring men’s and women’s pelvic health, announced today that its AMS 700® with INHIBIZONE® has been approved by the U.S. Food and Drug Administration...

160 - General Mills and American Dietetic Association Partner to Help Kids Across the U.S. Learn How to Eat Healthy and Stay Physically Fit

MINNEAPOLIS-(Business Wire)-July 15, 2009 - The General Mills Champions for Healthy Kids Program, in partnership with the American Dietetic Association, has awarded a half-million dollars in grants to community-based organizations across the U.S. for programs that support young people living...

161 - ReachMD Announces a New Radio Programming Series, “Diabetes Discourse,” hosted by Steven V. Edelman, MD

CHICAGO-(Business Wire)-July 15, 2009 - ReachMD, an innovative new media communications platform for medical professionals, is proud to bring “Diabetes Discourse” to thousands of medical professionals. Diabetes Discourse is sponsored by Novo Nordisk, a world leader in diabetes care. Diabetes...

162 - Peer-Reviewed Publications Demonstrate Tethys Bioscience’s Ability to Identify Those at Highest Risk of Developing Type 2 Diabetes Within Five Years

EMERYVILLE, Calif.-(Business Wire)-July 15, 2009 - As diabetes reaches epidemic proportions in the United States, clinicians struggle with a difficult question: how to prioritize their efforts to prevent the progression to diabetes in a population where more than 57 million Americans are currently...

163 - MannKind Announces Positive New Market Survey Information Regarding AFRESA®

VALENCIA, Calif.-(Business Wire)-July 14, 2009 - MannKind Corporation (Nasdaq: MNKD) today released new information related to the market potential for AFRESA, MannKind’s ultra rapid-acting insulin. In a market survey conducted in May 2009 involving 101 endocrinologists and 102 primary care...

164 - Research and Markets: South and Central America Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-July 14, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "South and Central America Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth...

165 - Halozyme Begins Phase 2 Clinical Trial of Insulin-PH20 in Type 2 Diabetic Patients

SAN DIEGO-(Business Wire)-July 14, 2009 - Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the...

166 - Selecting a Primary Care Physician Needs Careful Examination

BOCA RATON, Fla.-(Business Wire)-July 14, 2009 - What is a primary care physician? Why do I need one? How do I go about selecting one? Choosing the right primary care physician is critical to a patient’s healthcare strategy. But many people are not even aware of why they need one and what a...

167 - Research and Markets: South Africa Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-July 14, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "South Africa Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information...

168 - National Survey Indicates Latinos and Blacks in America Twice as Likely as Caucasians to Be Diagnosed with Diabetes

WASHINGTON-(Business Wire)-July 10, 2009 - CHI: WHO:   — Gary Puckrein, Ph.D., president and chief executive officer, National Minority Quality Forum — Amparo Gonzalez, director, Georgia Latino Diabetes Education Program at Emory University School of Medicine — Congresswoman...

169 - Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets in the United States

MINNEAPOLIS-(Business Wire)-July 10, 2009 - Medtronic, Inc. (NYSE:MDT) said today that it has initiated a recall of specific lots of Quick-set® infusion sets that are used with MiniMed Paradigm insulin pumps. An infusion set is a thin plastic tube used to deliver insulin from an insulin pump to a...

170 - Aetna Pilot Helps Physicians Improve Care for Diabetics

HARTFORD, Conn.-(Business Wire)-July 8, 2009 - Aetna (NYSE: AET) and Total Therapeutic Management (TTM) today announced the results of a pilot program in Southeastern Pennsylvania and South Florida that improved patient care and increased the number of physicians recognized by the National Committee...

171 - OSI Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 22, 2009

MELVILLE, N.Y.-(Business Wire)-July 8, 2009 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its second quarter 2009 financial results will be released on July 22, 2009, after the markets close. Following the announcement, OSI’s management will host a live conference call and...

172 - Southern California Physicians Managed Care Services Selects MedVentive as their Strategic HIT Partner

WALTHAM, Mass. and SAN DIEGO-(Business Wire)-July 7, 2009 - Southern California Physicians Managed Care Services (SCPMCS) announces the selection of MedVentive as its partner to provide a unified platform for assessing clinical and business drivers that will improve quality of care and lower...

173 - Research and Markets: Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-July 7, 2009 - Research and Markets data on market size by volume and value for categories in diabetes care devices market. It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global and country...

174 - Research and Markets: Israel Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 Offers Detailed and Comprehensive Coverage

DUBLIN-(Business Wire)-July 7, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Israel Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. Summary This report is an essential source for in-depth information...

175 - Maker of Prodigy Diabetes Monitoring Systems to Relocate Jobs to United States from Southeast Asia

CHARLOTTE, N.C.-(Business Wire)-July 7, 2009 - The distributor of Prodigy™ Blood Glucose Monitoring Systems, and the leading provider of audible blood glucose meters, has announced the relocation of manufacturing operations from Southeast Asia to Charlotte, North Carolina. “At a time when the...

176 - DRSI Launches the First and Only Diabetes Energy Formula Specifically Created for Diabetics to Counter Their No. 1 Complaint: Fatigue

BOCA RATON, Fla.-(Business Wire)-July 7, 2009 - Diabetica Research Solutions, Inc. (DRSI) www.drsirestoreenergy.com: Diabetes is a disease of energy currently affecting 24 million people who have been diagnosed and approximately 55 million who are in a pre-diabetic condition. For so many of these...

177 - Kineta Acquires Novel Drug Candidates from Airmid for Potential Treatment of Multiple Sclerosis, Type 1 Diabetes and other Autoimmune Diseases

SEATTLE-(Business Wire)-July 7, 2009 - Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds...

178 - Research and Markets: New Report - Asia-Pacific Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-July 7, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Asia-Pacific Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and...

179 - Research and Markets: New North America Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 Report

DUBLIN-(Business Wire)-July 6, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "North America Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information...

180 - Research and Markets: Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

DUBLIN-(Business Wire)-July 3, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Taiwan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. Taiwan Diabetes Care Devices Investment Opportunities, Analysis and...

181 - Research and Markets: Argentina Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 – Order Today

DUBLIN-(Business Wire)-July 3, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Argentina Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. Summary This report is an essential source for in-depth...

182 - Research and Markets: European Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 Report

DUBLIN-(Business Wire)-July 3, 2009 - Research and Markets has announced the addition of Global Markets Direct's new report "Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering. This report is an essential source for in-depth information and...

183 - Aetna Teams up with Bishop Eddie Long to Spread the Word about Preventing and Managing Diabetes

ATLANTA-(Business Wire)-July 2, 2009 - More than 300 members of Bishop Eddie L. Long’s Atlanta congregation at New Birth Missionary Baptist Church participated in diabetes screenings, and another 120 attended information sessions sponsored this week by Aetna (NYSE: AET) at the church’s...

184 - Home Diagnostics Added to Russell Indexes

FORT LAUDERDALE, Fla.-(Business Wire)-July 1, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it has been added to the Russell 3000®, Russell 2000® and Russell Global Indexes, effective as of June 26, 2009 after...

185 - INC Research Completes Acquisition of Global Clinical Development Unit of MDS Pharma Services

RALEIGH, N.C.-(Business Wire)-July 1, 2009 - INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced it has completed the acquisition of the Phase II-IV operations (Global Clinical Development) of MDS Pharma...

186 - Aushon Technology Chosen for Small Molecule Microarray Research

BILLERICA, Mass.-(Business Wire)-June 30, 2009 - Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis recently announced that the Eli and Edythe L. Broad Institute of MIT and Harvard will...

187 - Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements

WALTHAM, Mass.-(Business Wire)-June 30, 2009 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that GlaxoSmithKline (GSK) has signed multi-year, multi-million dollar contracts covering Licensing and Study Support...

188 - Reportlinker Adds Asia-Pacific Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

NEW YORK-(Business Wire)-June 30, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Asia-Pacific Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015...

189 - St. Joseph Health System Unveils Healthy for Life Recipes as Part of Campaign to Help Fight Childhood Obesity

ORANGE, Calif.-(Business Wire)-June 26, 2009 - Getting your children to trade in that tamale for a Jicama Popsicle this summer just got a lot easier, thanks to St. Joseph Health System’s (SJHS) Healthy for Life Campaign, an initiative aimed to improve the obesity rate among at-risk youth and their...

190 - Abbott Congratulates Team Type 1

ALAMEDA, Calif.-(Business Wire)-June 26, 2009 - As a proud sponsor of Team Type 1, Abbott Diabetes Care congratulates the team on its record-setting victory in the 2009 Race Across America (RAAM). Team Type 1’s victory in the eight-person rider division underscores how people with type 1...

191 - Santarus Joins the Russell 3000 Index

SAN DIEGO-(Business Wire)-June 26, 2009 - Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, today announced that it is set to join the Russell 3000® Index, which measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The...

192 - The Biomarkers Consortium Completes First Project to Show that Adiponectin is a Predictive Biomarker for Type 2 Diabetes

BETHESDA, Md.-(Business Wire)-June 25, 2009 - The use of adiponectin, a hormone derived from fat cells, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome proliferator-activated receptor-agonists (PPAR), but...

193 - ONGLYZA™ (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes

PARIS & LONDON-(Business Wire)-June 25, 2009 - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that their marketing authorization application for ONGLYZA™ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use...

194 - Weitz & Luxenberg Warns Public on Zicam, Other Homeopathic Remedies

NEW YORK-(Business Wire)-June 25, 2009 - Weitz & Luxenberg P.C. (weitzlux.com) would like to inform the public that so-called “homeopathic” remedies lack oversight by the U.S. Food and Drug Administration (FDA) and that some of these products, many of them marketed as “natural,” are...

195 - Home Diagnostics Launches TRUEmanager Diabetes Management Software

FORT LAUDERDALE, Fla.-(Business Wire)-June 24, 2009 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced the launch of TRUEmanager™ Diabetes Management Software. The advanced reporting features and new user-friendly interface...

196 - MDVIP Launches Preventive Medicine Pilot Program for Uninsured in Northern Virginia

BOCA RATON, Fla.-(Business Wire)-June 23, 2009 - On the heels of a successful partnership between MDVIP and Project Access in Palm Beach County, Florida, MDVIP will now roll out their second initiative to support the uninsured community in Northern Virginia. In collaboration with The INOVA Health...

197 - Redpoint Bio Identifies All-Natural Sweetness Enhancer For Use in Food and Beverages

EWING, N.J.-(Business Wire)-June 23, 2009 - Redpoint Bio Corporation (OTCBB:RPBC), a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, announced today that it has identified an all-natural sweetness enhancer, RP44...

198 - Avalon Healthcare Signs Contract with Manatee Memorial Hospital and Lakewood Ranch Medical Center

TAMPA, Fla.-(Business Wire)-June 23, 2009 - Avalon Healthcare, Florida’s fast growing statewide individual and group health insurance plan, has signed a provider agreement with Manatee Memorial Hospital and Lakewood Ranch Medical Center, announced Charles T. O’Neill, Avalon’s Chief Executive...

199 - Tranzyme Pharma CEO Vipin Garg Wins Ernst & Young Entrepreneur Of The Year® Award

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-June 23, 2009 - Tranzyme Pharma, a clinical stage biotechnology company, today announced that its President and CEO, Vipin K. Garg, PhD, received the Ernst & Young Entrepreneur Of The Year® 2009 Award in the health sciences category for the Carolinas...

200 - NERI Executive to Discuss Best Practices for Risk Mitigation Using Registries at 45th Annual DIA Meeting

WATERTOWN, Mass.-(Business Wire)-June 22, 2009 - Flora Sandra Siami, Director, Regulatory Affairs, at New England Research Institutes, Inc. (NERI), has been selected to present best practices for risk mitigation using registries at the 45th Annual Meeting of the Drug Information Association (DIA...

Search Our News Using Google Search

Can't find what you want? Try using Google:

	Enter your search terms Submit search form
	Web www.digital50.com

	Subscribe to our RSS feeds and get press releases delivered daily
	Subscribe to Business Press Releases in up to 210 Industries
	Add the DiGiTAL50 Search to your Site, FREE!